News Focus
News Focus
Followers 211
Posts 5042
Boards Moderated 1
Alias Born 02/11/2014

Re: Imvitium post# 12795

Thursday, 02/22/2018 1:44:55 AM

Thursday, February 22, 2018 1:44:55 AM

Post# of 13308
R/M is not recent, but it's commencement has been lingering due partly to US/international regulatory hurdles and management's top priority are it's Shantou and Brunei subsidiaries which are earning 10s of millions in revenue each year. Companies revenues have been slowly declining over the past few years and now it appears like they might tap into the otc entity for financing. That's why I'm here bc if they follow through, this will be much like JBZY/DOLV and perhaps better for the short while AS stays at 100mil

$$$BIGG


" Trust me, I am a Doctor "

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y